Simultaneous treatment with azelnidipine and olmesartan inhibits apoptosis of Hl-1 cardiac myocytes expressing E334k cMyBPC (HASIL TURNITIN)

Sobirin, Mochamad Ali (2019) Simultaneous treatment with azelnidipine and olmesartan inhibits apoptosis of Hl-1 cardiac myocytes expressing E334k cMyBPC (HASIL TURNITIN). Faculty of Medicine, Diponegoro University, Drug Res (Stuttg). 2013 Oct;63(10):515-20.

[img]
Preview
PDF (Hasil Turnitin) - Other
3316Kb
[img]
Preview
PDF (Hasil review)
174Kb

Item Type:Other
Subjects:R Medicine > RC Internal medicine
Divisions:Faculty of Medicine > Department of Medicine
Faculty of Medicine > Department of Medicine
ID Code:76624
Deposited By:INVALID USER
Deposited On:24 Sep 2019 15:35
Last Modified:17 Mar 2020 15:31

Repository Staff Only: item control page